Document Detail

Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery.
MedLine Citation:
PMID:  21856809     Owner:  NLM     Status:  In-Data-Review    
Purpose The effect of ascorbic acid on inflammatory markers after cardiothoracic surgery (CTS) was studied. Methods In this randomized, double-blind, placebo-controlled trial, patients undergoing cardiopulmonary bypass graft surgery or valve replacement surgery from April 2009 through March 2010 at Hartford Hospital were randomized to receive ascorbic acid (2-g loading dose followed by 500 mg every 12 hours) or matching placebo the evening before surgery and for four days postoperatively. Inflammatory mediators were measured preoperatively and on postoperative days 1-4. Intergroup comparisons were performed using two-tailed t tests and Fisher's exact test. Multiple comparisons were conducted using repeated analyses of variance with Bonferroni tests. Results Of the 62 patients screened, 24 met the study inclusion criteria. Of these, 13 were assigned to receive ascorbic acid and 11 received placebo. Ascorbic acid did not affect the natural course of inflammatory marker rise for C-reactive protein (CRP) concentration, white blood cell (WBC) count, or fibrinogen concentration versus placebo at any evaluated time point (p > 0.05 for all intergroup comparisons). Intragroup analyses demonstrated significant differences among baseline and postoperative measures of all inflammatory mediators (p < 0.05). No significant differences were noted in inflammatory markers between patients undergoing cardiothoracic surgery with or without cardiopulmonary bypass, regardless of treatment group. Conclusion Ascorbic acid did not attenuate the rise in inflammatory markers after CTS when compared with placebo. The use of off-pump surgery did not significantly change the levels of CRP and fibrinogen or the WBC count postoperatively when compared with on-pump surgery with a biocompatible polymer coating.
Jennifer A Colby; Wendy T Chen; William L Baker; Craig I Coleman; Kurt Reinhart; Jeffrey Kluger; C Michael White
Related Documents :
22100189 - Moist occlusive dressing (aquacel(®) ag) versus moist open dressing (mebo(®)) in the ...
25435879 - Are there clinical differences in limited systemic sclerosis according to extension of ...
21939609 - An electronic clinic for arthroplasty follow-up: a pilot study.
25361479 - The natural clinical course of hemodynamically stable adult moyamoya disease.
25298739 - Physician practicing preferences for conventional or homeopathic medicines in elderly s...
22234199 - Endoscopic third ventriculostomy in tubercular meningitis with hydrocephalus.
24769409 - Short- to medium-term outcomes after a modified brostrom repair for lateral ankle insta...
22947159 - Clinical and clinicopathologic abnormalities in young dogs with acquired and congenital...
19352169 - Postoperative neurocognitive dysfunction in elderly patients after xenon versus propofo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists     Volume:  68     ISSN:  1535-2900     ISO Abbreviation:  Am J Health Syst Pharm     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9503023     Medline TA:  Am J Health Syst Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1632-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Boxed warning inconsistencies between drug information resources and the prescribing information.
Next Document:  Factors associated with the publication of scholarly articles by pharmacists.